This document (page 13, Control Number 257) contains professional biographies for James Niedel and Liam Ratcliffe, executives at New Leaf Venture Partners. It details their educational backgrounds, board memberships, and extensive history in the pharmaceutical industry (GSK and Pfizer respectively), including specific successful drug developments and corporate acquisitions. The document is marked confidential and bears a House Oversight file stamp.
This document is a confidential financial appendix (Appendix 1) labeled 'Listing of Investments by Fund' for New Leaf Ventures II, L.P., dated March 31, 2014. It details the financial performance of numerous healthcare, therapeutic, and diagnostic companies in the fund's portfolio, split into realized/partially realized and unrealized investments. The document bears a House Oversight Committee stamp and a confidential control number, indicating it is part of a congressional investigation.
This document is page 29 of a bibliography or reference list, marked with a House Oversight Committee production stamp. It lists scientific citations (numbered 23-36) focusing on psychology, neuroscience, and sociology, specifically covering topics such as loneliness, social isolation, anthropomorphism, and the neural basis of social cooperation and rejection. The latest citation date is 2008, suggesting the document was compiled in or after that year.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity